Katarina Öhrling
- Oncology top 2%
- Epidemiology top 5%
- Neurology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Mark R. MiddletonMarja HallströmDavid EdlerPeter RagnhammarGerald DowneyKevin J. HarringtonRobert H.I. AndtbackaFrances A. Collichio
- Topics
- Colorectal Cancer Treatments and Studies (10 papers)Genetic factors in colorectal cancer (7 papers)CAR-T cell therapy research (6 papers)
- Cited by
- OncologyNeurologyEpidemiology
- Partner nations
- SwedenSwitzerlandUnited Kingdom
In The Last Decade
Katarina Öhrling
30 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.3k
- Epidemiology 759
- Neurology 482
- Molecular Biology 268
- Pulmonary and Respiratory Medicine 235
Countries citing papers authored by Katarina Öhrling
This map shows the geographic impact of Katarina Öhrling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Öhrling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Öhrling more than expected).
Fields of papers citing papers by Katarina Öhrling
This network shows the impact of papers produced by Katarina Öhrling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Öhrling. The network helps show where Katarina Öhrling may publish in the future.
Co-authorship network of co-authors of Katarina Öhrling
This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Öhrling. A scholar is included among the top collaborators of Katarina Öhrling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Öhrling. Katarina Öhrling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 31 | |
| 5 | 136 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 301 | |
| 9 | 18 | |
| 10 | 10 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 28 | |
| 14 | Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3) | 2 |
| 15 | 44 | |
| 16 | Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studybreakdown → | 714 |
| 17 | 10 | |
| 18 | 7 | |
| 19 | 25 | |
| 20 | 41 |
About Katarina Öhrling
Katarina Öhrling is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (7 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (1.3k citations), Neurology (482 citations) and Epidemiology (759 citations). Katarina Öhrling has collaborated with scholars based in Sweden, Switzerland and United Kingdom. Frequent co-authors include Mark R. Middleton, Marja Hallström, David Edler, Peter Ragnhammar, Gerald Downey, Kevin J. Harrington, Robert H.I. Andtbacka, Frances A. Collichio, Howard L. Kaufman and Matteo Biagini. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.